Sort
25,944 grants matching “neurodegeneration”
Neuropathology Core
$204,335Mark Cohen · Cleveland Clinic Lerner Com-Cwru · P30 · FY2021 · AG
The role of a novel tau-associated protein in neurodegeneration
$204,324Irving E Vega · University Of Puerto Rico Rio Piedras · SC1 · FY2009 · NS
Recombinant Human Lactoferrin for the Treatment of Chronic Inflammation in Older Adults.
$204,323Jeremy David Walston · Johns Hopkins University · R21 · FY2017 · AG
MICROGLIAL AND CYTOKINE SIGNATURES OF NEURODEGENERATION
$204,282Stephen M Gentleman · Univ Of Arkansas For Med Scis · P01 · FY2013 · AG
Liquid liquid phase separation and tau biology
$204,184Bradley T Hyman · Massachusetts General Hospital · R21 · FY2020 · AG
PATHOLOGY
$204,087Stephen J. Dearmond · University Of California, San Francisco · P01 · FY2013 · AG
Hypertension, brain clearance and markers of neurodegeneration
$203,904Lidia Glodzik · New York University School Of Medicine · R01 · FY2018 · NS
CA2+, ZN2+ AND SELECTIVE EXCITOTOXIC NEURODEGENERATION
$203,871University Of California Irvine · R01 · FY2000 · NS
Investigating the Molecular Mechanisms of Mitochondrial Calcium Uptake in Caenorhabditis elegans
$203,750Kenneth R Norman · Albany Medical College · R21 · FY2021 · AG
Early imaging markers for elderly individuals with high risk to develop Alzheimer's disease
$203,750Hanzhang Lu · Johns Hopkins University · R21 · FY2016 · AG
Research Education Component
$203,666Howard J Rosen · University Of California, San Francisco · P30 · FY2024 · AG
Mechanisms of neuronal cell death in synucleinopathies
$203,657Vivek Unni · Oregon Health & Science University · K02 · FY2016 · NS
Inflammation and Renin-Angiotensin System Dysfunction as risk factors for AD
$203,634Whitney Lee Wharton · Emory University · RF1 · FY2017 · AG
CROSSED GENETIC RISK OF ALZHEIMER AND PARKINSON DISEASE
$203,289Allan I Levey · Emory University · P50 · FY2007 · AG
Overexpression of Complement in the Brain and HIV Neuropathogenesis
$203,250David J Volsky · St. Luke'S-Roosevelt Inst For Hlth Scis · R21 · FY2009 · MH
Determining the influence of cellular environments on a-synuclein fibril conformations
$203,203Kendra King Frederick · Ut Southwestern Medical Center · R21 · FY2025 · NS
Interleukin-1 and Memory Loss in Aging
$203,185Carmelina Gemma · University Of South Florida · R21 · FY2006 · AG
Suppression of the heat shock response in aging and neurodegeneration
$203,125Michael Y Sherman · Boston University Medical Campus · R21 · FY2009 · AG
Systematic and mechanistic assessment of the roles of circRNAs in Alzheimer's Disease
$203,125Sebastian Kadener · Brandeis University · R21 · FY2024 · AG
The Role of the FOXO Pathway in the Control of Transposons in Aging
$203,125Michael Thomas Marr · Brandeis University · R21 · FY2018 · AG
Moderate-throughput screening for anti-epileptogenic drugs.
$203,075Kevin J. Staley · Massachusetts General Hospital · R21 · FY2012 · NS
Develop an ANS-based Personalized Cognitive Training for Mild Cognitive Impairment
$203,015Feng Vankee Lin · Stanford University · R21 · FY2022 · AG
ATM Regulation via PP2A and Ceramide
$203,000Helen H Chun · California State Univ-Dominguez Hills · R15 · FY2007 · GM
Characterization of brain atrophy in Huntington?s disease mouse model
$202,922Jiangyang Zhang · Johns Hopkins University · R21 · FY2009 · NS
CORE--NEUROPATHOLOGY/BRAIN BANK
$202,834Mount Sinai School Of Medicine Of Nyu · P01 · FY2002 · AG